Infliximab and nephrotic syndrome

G. Chin, G. Luxton, Jennet Harvey

    Research output: Contribution to journalArticlepeer-review

    29 Citations (Scopus)


    Infliximab is a chimeric tumor necrosis factor-alpha (TNF-alpha) monoclonal antibody, which has been used extensively in patients with rheumatoid arthritis and inflammatory bowel disease. It also appears to be effective in other conditions such as psoriasis and ankylosing spondylitis. The major side effect of infliximab is infection. Renal complications are uncommon and not well recognized. This report describes a probable case of infliximab-induced membranous nephropathy.
    Original languageEnglish
    Pages (from-to)2824-2826
    JournalNephrology Dialysis Transplantation
    Publication statusPublished - 2005


    Dive into the research topics of 'Infliximab and nephrotic syndrome'. Together they form a unique fingerprint.

    Cite this